Wachovia Upgrades Alcon (ACL) to Outperform, Strong Chance Company Acquired by Novartis (NVS)
Tweet Send to a Friend
Wachovia upgrades Alcon (NYSE: ACL) to Outperform.
Wachovia analyst says, "ACL's stock has retreated and valuation is reasonable, in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wachovia analyst says, "ACL's stock has retreated and valuation is reasonable, in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
